News
The European Commission has granted marketing authorization for Gilead Sciences' twice-yearly injection for preventing HIV infection, the company said on Tuesday.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted marketing authorization ...
36m
Investor's Business Daily on MSNGilead Sciences' 99.9% Effective HIV Treatment Notches Another Win
Gilead Sciences won European approval Tuesday for its new twice-annual HIV prevention shot, now called Yeytuo.
At the International AIDS Society meeting this year, a young woman from South Africa spoke. She is the first Black woman from ...
In this article, we will take a detailed look at the Top 10 Trending Stocks to Watch Ahead of Nvidia Earnings.
15h
Daily Maverick on MSNDoes SA need a Covid-like ministerial advisory committee to deal with HIV funding cuts?
Health Minister Aaron Motsoaledi said in July he would ‘strongly consider’ a ministerial advisory committee, like the one we ...
On Friday, the U.S. District Court for the District of Maryland paused several parts of a health insurance exchange enrollment and eligibility rule that was set to take effect today. The court agreed ...
CVS is opting against covering a twice-yearly injectable HIV prevention drug, drawing criticism from advocates who are ...
In the mid-1990s, clinicians treating people with HIV began to notice a syndrome characterized by loss of limb fat, facial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results